-
Mashup Score: 0WCLC Sept 2021 Archives | VJOncology - 3 year(s) ago
08–14 September 2021 | Virtual Meeting The 2021 World Conference on Lung Cancer, held between the 8th and 14th September will bring together the largest international gathering of clinicians, researchers and scientists in the field of lung cancer thoracic oncology. View all videosToday’s #GICancer roundtable starts in 1 hour The expert panel will be talking about the exciting upper GI…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 02021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
A session at #WCLC21 highlighted the need for mental health support for patients with #lungcancer during the COVID-19 pandemic. Read a recap: https://t.co/GjChA9l6ux #LCSM https://t.co/9rigBTbZJ5
-
-
Mashup Score: 12021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
#WCLC21 attendees were able to learn about socioeconomic disparities among patients with MPM. Find out more in WCLC Meeting News: https://t.co/pQ1roPrMP1 #LCSM https://t.co/ZyUU1B9suW
-
-
Mashup Score: 142021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Oncs, Latest HeadlinesTweet
-
🚨⭐️Just saw the first page of #WCLC news. Pre-pandemic we call it throw aways. Post-pandemic should we make them into a digital NFT ? Our analysis of lurbinectedin & platinum-sensitive #SCLC was in the spotlight #WCLC21. Read a recap @OncoAlert @IASLC : https://t.co/nUp7YnJrbz https://t.co/s7e3pOEIiA
-
🚨⭐️Just found out that our analysis of lurbinectedin and platinum-sensitive #SCLC was in the spotlight at #WCLC21. Read a recap in WCLC Meeting News @OncoAlert @IASLC : https://t.co/nUp7YnJrbz #LCSM https://t.co/5reqDB8wfF
-
-
Mashup Score: 02021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
ICYMI at #WCLC21: Catch up on coverage of the Presidential Symposium, Opening Plenary, and more in this final edition of WCLC Meeting News. https://t.co/uEJD8Eh685 #LCSM https://t.co/W1V7Ndf9Gj
-
-
Mashup Score: 02021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
ICYMI at #WCLC21: Catch up on coverage of the Presidential Symposium, Opening Plenary, and more in this final edition of WCLC Meeting News. https://t.co/bogHtTQ6aw #LCSM https://t.co/giBxvRObwn
-
-
Mashup Score: 2Dual Checkpoint Blockade Plus Chemotherapy Improves Survival in First-Line Metastatic NSCLC - The ASCO Post - 3 year(s) ago
The combination of dual checkpoint inhibition plus chemotherapy could be the new standard of care in first-line metastatic non–small cell lung cancer (NSCLC), according to data presented during the International Association for the Study of Lung Cancer (IASLC) 2021 World Conference on Lung Cancer.1 Findings from the…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
POSEIDON Trial: Dual Checkpoint Blockade Plus Chemotherapy Improves Survival in First-Line Metastatic NSCLC https://t.co/pfSm6kklzk #wclc21 #oncology #cancer #LCSM
-
-
Mashup Score: 1Phase II Trial Finds Atezolizumab of Benefit in Patients With Lung Cancer and Brain Metastases - The ASCO Post - 3 year(s) ago
Patients with non–small cell lung cancer (NSCLC) and brain metastasis derived significant benefit from treatment with the monoclonal antibody atezolizumab plus chemotherapy, according to the multicenter phase II Atezo-Brain trial.1 The study was presented at the International Association for the Study of Lung Cancer…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Phase II Trial Finds Atezolizumab of Benefit in Patients With Lung Cancer and Brain Metastases https://t.co/9B8LpmMk8h #LCSM #oncology #cancer #wclc21
-
-
Mashup Score: 7Pretreatment Levels of Circulating Tumor DNA May Predict Long-Term Survival in NSCLC - The ASCO Post - 3 year(s) ago
Pretreatment circulating tumor DNA (ctDNA) levels in patients with non–small cell lung cancer (NSCLC) appear to be a more accurate predictor of long-term survival than classic survival surrogates, according to research presented during the International Association for the Study of Lung Cancer (IASLC) 2021 World…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ASCOPost: Pretreatment Levels of Circulating Tumor DNA May Predict Long-Term Survival in NSCLC https://t.co/J720ynuvLB #LCSM #oncology…
-
Pretreatment Levels of Circulating Tumor DNA May Predict Long-Term Survival in NSCLC https://t.co/J720ynuvLB #LCSM #oncology #cancer #wclc21
-
-
Mashup Score: 02021 WCLC Meeting News: Post Edition - 3 year(s) agoSource: digitaledition.tristar.solutionsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
A study looked at age's effect on the survival benefit of ICIs in stage IV #NSCLC. Learn about the results presented at #WCLC21: https://t.co/QW9Ek2TMUL #LCSM https://t.co/fkhRqdNSbR
-
It’s #LungCancerAwarenessMonth! Why not check out some of our interviews with leading experts from the World Conference on Lung Cancer and stay up to date 🎥 Watch here: https://t.co/vK71342Np8 @VJOncology #LCSM #LungCancer #LCAM #LCAM21 #WCLC21 @IASLC